Sponsor or institution

Clinical trials and research at Inmunotek S.L.

• 9Clinical trials
• 2New in 30 days
• 4Countries

Newest trials

All recruiting trials (9)

• Mannan-Conjugated Allergoids for House Dust M mite Allergy

  A new treatment named EP-088_MM09 is being tested to see if it can reduce nasal and eye allergy symptoms (and possibly asthma) in people aged 12 to 65 who are allergic to house dust mites, compared with a placebo.

  Recruiting at 2 sites Phase 3 Inmunotek S.L. · Covilha, Castelo Branco District and 15 other locations · NCT07904195

• Mannan-conjugated Allergoids for House Dust Mite Allergy

  A new treatment called EP-088_MM09 is being tested to see if it can reduce allergy symptoms in people with house dust mite–related nasal allergy, with or without mild asthma.

  Recruiting at 4 sites Phase 3 Inmunotek S.L. · Coimbra and 15 other locations · NCT07904052

• Sublingual MM09 for dust-mite–triggered rhinitis and rhinoconjunctivitis in people aged 12–65 with or without mild-to-moderate asthma

  This trial will test whether daily sublingual MM09 reduces symptoms and the need for rescue medication in people aged 12–65 who have rhinitis or rhinoconjunctivitis caused by dust mites, with or without mild-to-moderate asthma.

  Recruiting at 14 sites Phase 3 Inmunotek S.L. · Nueve de Julio, Buenos Aires and 18 other locations · NCT07348302

• Immunotherapy for treating insect venom allergies.

  This study is testing a new treatment for people aged 14 and older with insect venom allergies to see if it can safely reduce their allergic reactions in real-life situations.

  Recruiting at 3 sites Inmunotek S.L. · Alcorcón, Madrid and 2 other locations · NCT06790368

• Evaluating the safety of immunotherapy for insect venom allergy

  This study is testing the safety of a new treatment for people aged 14 and older with insect venom allergies to see how well it works and if it causes any side effects.

  Recruiting at 8 sites Inmunotek S.L. · Ferrol, A Coruña and 8 other locations · NCT06782217

• Standardizing allergen extracts from Quercus ilex and Quercus robur

  This study is testing how strong allergen extracts from two types of oak trees are to help people with allergies by using skin tests and blood samples.

  Recruiting Inmunotek S.L. · Madrid · NCT05532566

• Evaluating a new treatment for allergies to certain trees and grasses

  This study is testing a new allergy treatment for people aged 12 to 65 who are sensitive to certain tree and grass pollens to see if it can help reduce their allergy symptoms.

  Recruiting at 9 sites Phase 3 Inmunotek S.L. · Valladolid, Castille and León and 26 other locations · NCT04898283

• Evaluating a treatment for allergies to grass and olive pollen

  This study is testing a new allergy treatment for people aged 12 to 65 who have reactions to grass and olive pollen to see if it can help reduce their symptoms.

  Recruiting at 22 sites Phase 3 Inmunotek S.L. · Tarancón, Cuenca and 31 other locations · NCT04891237

• Evaluating a treatment for allergies to dust mites

  This study is testing a new allergy treatment for people aged 12 to 65 who are sensitive to dust mites to see if it can help reduce their allergy and asthma symptoms over a year.

  Recruiting at 22 sites Phase 3 Inmunotek S.L. · Santiago de Compostela, A Coruña and 31 other locations · NCT04435990

Quick answers

How many clinical trials run by Inmunotek S.L. are recruiting right now?

9, as of November 12, 2026. 2 of them were first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 4 countries. The most sites are in Spain (9 trials), Portugal (3 trials), Argentina (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 6. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →